CD274 and neoplasm: PD-L1 protein at baseline was evaluated for six patients (one patient provided both archival tissue and newly obtained biopsy) in three archival tissue sections and four newly obtained biopsies using a fully validated IHC test that determines levels of PD-L1 expression on both tumor cells (TC+) and infiltrating immune cells (IC+).